Navigation Links
New Dean of School of Medicine and Dentistry Announced
Date:1/19/2010

Berk Prepares to Return as CEO

ROCHESTER, N.Y., Jan. 19 /PRNewswire-USNewswire/ -- University of Rochester President Joel Seligman today announced that on March 1, Bradford C. Berk, M.D., Ph.D., will return as full-time CEO of the Medical Center while Mark B. Taubman, M.D., will begin serving as the tenth dean of the University of Rochester School of Medicine and Dentistry.  

"I am excited to return as CEO, and I'm immensely grateful to all those who maintained the Medical Center's progress in my absence," Berk said.  "This experience has provided me with a fresh view of what it's like to be a patient.  There are huge opportunities for us as an institution and an organization. I'm very energized by the great things we can accomplish at the Medical Center."  

The former chair of the Department of Medicine, Taubman has been serving as Acting CEO of the Medical Center since Berk suffered a serious spinal cord injury on May 30, 2009.  With Berk now returning as CEO, Taubman will become Medical School dean and remain a pivotal member of Berk's leadership team.  Until Berk returns, Taubman will continue as Acting CEO.

"Mark has performed admirably over the last several months as Acting CEO.  He has not only maintained the Medical Center's forward momentum, he led the Medical Center's leadership team in solving some challenging issues," said University of Rochester President Joel Seligman. "I wholeheartedly support his selection as Dean of the Medical School."  

"Mark is the best possible choice for Dean," Berk said. "He is a physician-scientist who is active in the laboratory yet possesses a broad institutional view. As an active cardiologist, he also understands the challenges of practicing medicine."  

Taubman came to the Medical Center as chief of the Cardiology Unit and Paul N. Yu Professor of Medicine in February 2003. As chief, he was the guiding force behind the expansion of cardiac patient care services, faculty recruitment, strengthening treatments for those with heart arrhythmias and heart failure, adding new preventive cardiology programs such as the women's heart program, and forging strong regional services. Taubman also served as director of the Aab Cardiovascular Research Institute, which he helped Berk to found.

Taubman became chair of the Department of Medicine and Charles E. Dewey Professor of Medicine in May 2007. As chair of Medicine, he directed the largest single department in the Medical Center with more than 1,000 faculty and staff who work in 10 units devoted to patient care, research, and education, and a $150 million budget. He named division chiefs, including General Medicine, Cardiology, Hematology-Oncology, Endocrinology, and Infectious Disease. He also appointed an associate chair for Research as well as a chief financial officer for Medicine.  

In 2006, Taubman was named editor-in-chief of Arteriosclerosis, Thrombosis and Vascular Biology, one of five international medical journals published by the American Heart Association, and the leading journal in the field of vascular biology. He has more than 120 publications, chapters and scholarly writings to his credit. 

Taubman is a graduate of the New York University School of Medicine who interned at Peter Bent Brigham Hospital before completing his residency and cardiology fellowship training at the Brigham & Women's Hospital.  He held academic appointments at Harvard Medical School, Children's Hospital Boston, and Mt. Sinai School of Medicine. Prior to being recruited to the University of Rochester, he was director of cardiovascular research at Mt. Sinai.

According to Taubman, in the weeks ahead, a national search for his replacement as chair of Medicine will be led by current chair of Surgery, Jeffrey Peters, M.D.  He expressed his thanks to Paul Levy, M.D., who has functioned as Acting Chair of Medicine since Taubman has filled in as Acting CEO. Seligman, Taubman, and Berk also praised the work of Elizabeth "Lissa" McAnarney, M.D., chair emerita of Pediatrics who has been serving as Interim Dean since June.  

"Lissa is a seasoned academician whose leadership has been invaluable over these last several months," Seligman said.  "By stepping forward to steer the school through this transitional period, Lissa has given us the opportunity to make a thoughtful, deliberate choice that's ideal for the School of Medicine and Dentistry and the Medical Center.  We owe her a debt of gratitude."  

SOURCE University of Rochester Medical Center

RELATED LINKS
http://www.urmc..rochester.edu

'/>"/>

SOURCE University of Rochester Medical Center
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Worlds #1 Health Brand for Kids Joins Forces With Worlds #1 In-School Childrens Theatre
2. Capital BlueCross Partners with Department of Health, Area Schools to Encourage Students to Lead Active, Healthy Lifestyles
3. Hepatitis B Foundation awards UT School of Public Health professor
4. Short School Closures Wont Shut Down Flu
5. NEH grant to Center for History and Ethics of Public Health at Columbias Mailman School
6. Update on vitamins and diabetic retinopathy; ethnic norms for preschoolers eyesight
7. New Online Program Gives Parents and Schools an Innovative Tool to Prevent Substance Use Among Youth
8. American University of Antigua Becomes First International School to Administer Web-Based NBME Exam
9. School classroom air may be more polluted with ultrafine particles than outdoor air
10. State Health, Education Leaders Recognize Berks County Middle School for Boosting Physical Activity Among Students
11. Teams And Tournament Schedule Finalized For The Dr. Alec Kessler Memorial High School Basketball Invitational December 28-30, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... ... December 04, 2016 , ... ... surgery can now take advantage of a cosmetic procedure known as Carbon ... that reduces the appearance of age spots, fine lines, uneven coloration, wrinkles, ...
(Date:12/2/2016)... ... , ... Lori G. Cohen and Sara K. Thompson , ... American Conference Institute’s 21st Drug & Medical Device Litigation Conference , taking place ... conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device & Health Care Litigation ...
(Date:12/2/2016)... ... December 02, 2016 , ... More than ... Alabama are expected to attend the UNCF Dothan-Wiregrass Mayor’s Luncheon Dec. 9, 2016. ... for area students and operating support to UNCF-member institutions, including Miles College, Oakwood ...
(Date:12/2/2016)... , ... December 02, 2016 , ... The annual time ... Period (or Annual Election Period), is ending December 7th. Currently-enrolled Medicare beneficiaries who are ... or prescription drug plan (Part D) need to make changes during this period order ...
(Date:12/2/2016)... Hills, CA (PRWEB) , ... December 02, 2016 ... ... reconstructive surgeon in Beverly Hills, California, will be included in the 2016 “Guide ... given to exceptional professionals based on the amalgamation of their education, experience, and ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... , Dec. 2, 2016 The U.S. ... for Jardiance (empagliflozin) to reduce the risk of cardiovascular ... and cardiovascular disease. "Cardiovascular disease is ... 2 diabetes mellitus," said Jean-Marc Guettier , M.D., ... Products in FDA,s Center for Drug Evaluation and Research. ...
(Date:12/2/2016)... , December 2, 2016 bioLytical Laboratories, un líder ... Compañía, el INSTI HIV Self Test , a los miembros de la ... ... INSTI HIV Self Test! (PRNewsFoto/bioLytical Laboratories) ...      (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) bioLytical ...
(Date:12/2/2016)... the ECG Cables And ECG Leadwires Market owing to the ... On the other hand, the Asia-Pacific ... during the forecast period. The market players namely, ... ( Ireland ), Koninklijke Philips N.V. ( ... China ), held major share of the ECG ...
Breaking Medicine Technology: